Rockefeller Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
OHA
Rockefeller Capital Management's EBS Position: Q2 2026 in Review
Rockefeller Capital Management reduced its Emergent Biosolutions (EBS) stake by 11% in Q2 2026, selling an estimated $962 and leaving 941 shares worth $7.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4102.
Rockefeller Capital Management first reported a position in EBS in Q1 2019 and has held it in 18 quarters since. The position peaked at $94K in Q3 2020. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- Rockefeller Capital Management held 941 shares of Emergent Biosolutions worth $7.89K as of Q2 2026.
- Rockefeller Capital Management sold 115 Emergent Biosolutions shares in Q2 2026, an estimated $962.
- Emergent Biosolutions made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4102 holding.
- Rockefeller Capital Management first reported a position in Emergent Biosolutions in Q1 2019 and has held it in 18 quarters since.
- Rockefeller Capital Management's Emergent Biosolutions position peaked at $94K in Q3 2020.
- 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.